E.E.S. 200 Drug Patent Profile
✉ Email this page to a colleague
When do E.e.s. 200 patents expire, and when can generic versions of E.e.s. 200 launch?
E.e.s. 200 is a drug marketed by Arbor Pharms Llc and is included in one NDA.
The generic ingredient in E.E.S. 200 is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for E.e.s. 200
A generic version of E.E.S. 200 was approved as erythromycin ethylsuccinate by ARBOR PHARMS LLC on December 31st, 1969.
Summary for E.E.S. 200
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 54 |
Patent Applications: | 1,569 |
Formulation / Manufacturing: | see details |
DailyMed Link: | E.E.S. 200 at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for E.E.S. 200
US Patents and Regulatory Information for E.E.S. 200
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Arbor Pharms Llc | E.E.S. 200 | erythromycin ethylsuccinate | SUSPENSION;ORAL | 061639-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |